z-logo
Premium
Case of chronic‐phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin
Author(s) -
Sakakura Miho,
Ohishi Kohshi,
Nomura Kenichi,
Katayama Naoyuki,
Nishii Kazuhiro,
Masuya Masahiro,
Nakase Kazunori,
Shiku Hiroshi
Publication year - 2004
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.20165
Subject(s) - chronic myelogenous leukemia , fluorescence in situ hybridization , medicine , imatinib mesylate , clone (java method) , pathology , imatinib , bone marrow , lymph node , cd34 , leukemia , breakpoint cluster region , gene rearrangement , philadelphia chromosome , cancer research , immunology , biology , chromosomal translocation , stem cell , myeloid leukemia , chromosome , gene , biochemistry , genetics , receptor
We report a 59‐year‐old man with chronic myelogenous leukemia (CML) in chronic phase who presented with a large abdominal tumor. Biopsy revealed proliferation of granulocytic‐, erythroid‐, and megakaryocytic‐lineage cells in a retroperitoneal lymph node. The BCR/ABL fusion gene was detected on a paraffin‐embedded tissue section of the lymph node by double‐color fluorescence in situ hybridization, indicating an extramedullary hematopoietic tumor of CML origin. This patient has achieved a complete cytogenetic response for 19 months with imatinib mesylate (STI571; Gleevec), in association with the regression of the tumor. However, the development of an extramedullary tumor in chronic‐phase CML generally indicates a poor prognosis, because it commonly consists of blast proliferation and is followed by blast crisis in the marrow within a few months. This case, therefore, points to the importance of histological examination of extramedullary tumors in CML for evaluation of disease status and for therapeutic decisions. Am. J. Hematol. 77:167–170, 2004. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom